DESFECHO: PRESSÃO PARCIAL DE OXIGÊNIO ARTERIAL PELA FRAÇÃO INSPIRADA DE OXIGÊNIO (PaO2/FiO2) mmHg
4.12 ESPIROMETRIA DE INCENTIVO (sozinha) e ESPIROMETRIA DE INCENTIVO ASSOCIADA À FISIOTERAPIA PÓS-OPERATÓRIA CONVENCIONAL VERSUS FISIOTERAPIA PÓS-OPERATÓRIA CONVENCIONAL.
DESFECHO: PNEUMONIA
Autor, Ano Descrição Espirometria de
Incentivo n/N Controle n/N OR IC 95% p
Jenkins, 1989 EI x Fisiot.PO conv 2/38 4/35 0,45 [0,08;2,35] p=0,34
Crowe, 1997 EI + Fisiot PO conv x
Fisiot. PO conv.
8/90 10/95 0,83 [0,31;2,19] p=0,71
Total (IC 95%) Total de eventos
(n)/total de
participantes (N) 10/128 14/130 0,71 [0,31;1,64] p=0,42
EI: espirômetro de incentivo; PO:pós-operatória; IC: intervalo de confiança; OR: odds ratio (chance de ocorrência do evento); n: número de participantes com ocorrência do evento; N: número total de participantes.
4.13 ESPIROMETRIA DE INCENTIVO EXCLUSIVA (sozinha) e ESPIROMETRIA DE INCENTIVO ASSOCIADA À FISIOTERAPIA PÓS-OPERATÓRIA CONVENCIONAL VERSUS FISIOTERAPIA PÓS-OPERATÓRIA CONVENCIONAL.
DESFECHO: VOLUME EXPIRATÓRIO FORÇADO NO PRIMEIRO SEGUNDO (VEF1) (ml)
Autor, Ano Descrição N Espirometria de
incentivo Média (DP) N Controle Média (DP) DMP (Fixo) IC 95% p Jenkins, 1989 EI x Fisiot. PO conv 38 1700 (450) 35 1700 (350) 0,00 [-184,16;184,16] p=1,00 Crowe, 1997 EI + Fisiot PO conv. x Fisiot. PO conv. 90 1045 (270) 95 990 (270) 55,00 [-22,84;132,84] p=0,17 Total (IC 95%) 128 130 46,66 [-25,04;118,36] p=0,20
EI: espirômetro de incentivo; PO: pós-operatória; IC: intervalo de confiança; DMP: diferença da média ponderada; N: número total de participantes; DP: desvio padrão.
4.13 ESPIROMETRIA DE INCENTIVO EXCLUSIVA (sozinha) e ESPIROMETRIA DE INCENTIVO ASSOCIADA À FISIOTERAPIA PÓS-OPERATÓRIA CONVENCIONAL VERSUS FISIOTERAPIA PÓS-OPERATÓRIA CONVENCIONAL
DESFECHO:TEMPO DE PERMANÊNCIA HOSPITALAR (dias)
Autor, Ano Descrição N Espirometria de
incentivo Média (DP) N Controle Média (DP) DMP (Fixo) IC 95% p Crowe, 1997 EI + Fisiot PO conv. x Fisiot. PO conv. 90 9 (3,10) 95 9,7 (4,9) -0,70 [-1,88;0,48] p=0,24 Total (IC 95%) 90 95 -0,70 [-1,88;0,48] p=0,24
EI: espirômetro de incentivo; PO: pós-operatória; IC: intervalo de confiança; DMP: diferença da média ponderada; N: número total de participantes; DP: desvio padrão.
1. Anderson RW; Milano CA. Cardiopatia adquirida: Insuficiência Coronária. In: Townsend CM; Beauchamp RD; Evers BM; Mattox KL. Sabiston – Tratado de Cirurgia. As bases biológicas da prática cirúrgica moderna. Rio de Janeiro:
Editora Guanabara Koogan S.A; 2003. p. 1391-1425.
2. Eagle KA, Guyton RA, Davidiff R, et al. ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) /American College of Cardiology/American Heart Association. J Am Coll Cardiol 1999; 34:1262- 1347.
3. Calvin SH, Song Wan MD, Antony PC Yim, Ahmed AA. Pulmonary dysfunction after cardiac surgery. Chest 2002; 121(4): 1269-1277.
4. Barnas GM, Gilbert TB, Watson RJ, et al. Respiratory mechanics in the open chest: Effects of parietal pleurae. Respir Physiol 1996; 104: 63-70.
5. Gilbert TB, Barnas GM, Siqueira AJ. Impact of pleurotomy, continuous positive airway pressure, and fluid balance during cardiopulmonary bypass on lung
mechanics na oxigenation. J Cardiothorac Vasc Anesth1996; 10: 844-849.
6. Senra DF, Labesch JA, Oliveira SA. Pós-operatório em cirurgia cardíaca de adultos. Rev Soc Cardiol Estado de São Paulo 1998; 8(3): 446-454.
7. Brooks-Brunn JA. Postoperative atelectasis and pneumonia. Heart lung 1995; 24:94-15.
8. Ferguson MK. Preoperative assessment of pulmonary risk. Chest 1999; 115: 58S –63S
9. Magnusson, Spahn DR. New concepts of atelectasis during general anaesthesia. Br J Anaesth2003; 91: 61-72.
10. Westerdahl E, Lindmark B, Eriksson T, Friberg Ö, Hedenstierna G, Tenling A. Deep-Breathing Exercises Reduce Atelectasis and Improve Pulmonary Function After Coronary Artery Bypass Surgery. Chest 2005; 128: 3482-3488.
11. Wilcox P, Baile EM, Hards J, et al. Phrenic nerve function and it’s relationship to atelectasis after coronary bypass surgery. Chest 1988; 93: 693-698.
12. Craig DB. Postoperative recovery of pulmonary function. Anesth Analg 1981; 60(1):46-52
13. Latimer RG, Dickman M, Day WC, Gunn ML, Schimidt CD. Ventilatory patterns and pulmonary complications after upper abdominal surgery determined by preoperatory and postoperative computadorized spirometry and blood gas analysis. Am J Surg 1971; 122(5):622-32.
14. Ghattas MA. Pulmonary dysfunction after coronary artery bypass. Cleve Clin J Med 1981; 48(1):218-220.
15. Bartlett RH: Pulmonary pathophysiology in surgical patients. Surg Clin North Am
1980; 60(6):1323-1337.
16. Dureuil B, Cantinueau JP, Desmonts JM. Effects of upper and lower abdominal
surgery on diaphragmatic function. Br J Anaesth 1987; 59: 1230-35.
17. Craven JL, Evans GA, Davenport PJ, Williams RHP. The evaluation of incentive spirometry in the management of postoperative pulmonary
18. Tan AK. Incentive spirometry for tracheostomy and laringectomy patients. J Otolaryngol 1995; 24: 292-294.
19. Galvan CCR; Cataneo AJM. Fisioterpia aplicada às condições cirúrgicas. In: Cataneo AJM; Kobayashi S. Clínica cirúrgica – Cirurgia torácica, gastrocirurgia, cirurgia vascular, cirurgia cardíaca, cirurgia pediátrica, urologia e cirurgia plástica. Faculdade de medicina de Botucatu – UNESP. Rio de Janeiro: Revinter; 2003. p. 42-52.
20. CPCRS and Cardiorespiratory Division: Cardiorespiratory Physical Therapy-
Current Issues, Future Directions. CPCRS and Cardiorespiratory Division of
CPA Newsletter, December 1998.
21. Bartlett RH, Gazzaniga AB & Geraghty TR. Respiratory maneuvers to prevent postoperative pulmonary complications. A critical review. JAMA 1973; 224(7): 1017-021.
22. Stiller KR, Munday RN. Chest physiotherapy for the surgical patient. Br J Surg
1992; 79(8):745-9.
23. Bartlet RH, Krop P, Hanson EL, Moore FD. Physiology of yawning and its application to postoperative care. Surg Forum 1970; 21: 223-224.
24. Hilling L, Bakow E, Fink J, Kell C Sobush D, Southorn AP. AARC Clinical Practice Guideline Incentive Spirometry. Respir Care 1991; 36: 1402-1405.
25. Petz TJ. Physiologic effects of IPPB, blow blottes and incentive spirometry. Curr Rev Respir Ther 1979; 1:107-111.
26. Meyers JR, Lembrck L, O´Kane H, Baue AE. Changes in residual capacity of the lung after operation. Arch Surg 1975; 110: 567-583.
27. Pasquina P, Tramer MR, Walder B. Prophylactic respiratory physiotherapy after
cardiac surgery: systematic review. Br Med J (BMJ) 2003; 327(7428): 1379-
1385.
28. Brooks D, Crowe J, Kelsey CJ, Lacy JB, Parsons J, Solway S. A clinical practice guideline on peri-operative cardiorespiratory physical therapy. Physiother Can
2001; 9-25.
29. Overend TJ, Anderson CM, Lucy SD, Bhatia C, Jonsson BI & Timmermans C. The effect of incentive spirometry on postoperative pulmonary complications. A Systematic Review. Chest 2001; 120(3): 971-978.
30. Thomas JA, Mcntosh JM. Are incentive spirometers, intermittent positive pressure breathing, and deep breathing exercises effective in the prevention of
postoperative pulmonary complications after upper-abdominal surgery: a
systematic overview and meta-analysis. Phys Ther 1994; 74:3-10.
31. Mulrow CD, Cook DJ, Davidoff F. Systematic review: Critical links in the great chain of evidence. Ann Intern Med 1997; 126: 389-391.
32. Chalmers I, Altman D, editors. Systematic reviews. Plymouth: Br Med J (BMJ) 1995; Publishing Group.
33. Clarke M, Oxman AD, editors. Cochrane Reviewers’ Handbook 4.1.6 [updated January 2003]. In: The Cochrane Library, Issue 1, 2003. Oxford: Update Software. Updated quarterly.
34. Kannel WB. Contribution of the Framinghan heart study to preventive cardiology. Bishop lecture. J Am Coll Cardiol 1990; 15: 206-211.
35. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 1976; 37: 289-292.
36. Kannel WB. New perspectives in cardiovascular risk factors. Am Heart J 1987; 114:213-219.
37. Report of intersociety commission for heart disease resourses. Optional resources for primary prevention of atherodclerotic disease. Circulation 1984;
70: 157A-205A.
38. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
39. Eptein FH. Predicting, explaining, and preventing coronary heart disease. An epidemiological view. Mod Concepts Cardiovasc Dis1979; 48: 712.
40. Higgins M, Kannel WB, Garrison R, Pinski J, Stokes J, III. Hazards of obesity. The Framigham experience. Acta medica Scandinavica [Suppl] 1988; 723-23-36.
41. Kannel WB, Wilson PWF, Blair SN. Epidemiologic assessment of role of physical activity and fitness in development of cardiovadcular disease. Am Heart J 1985; 109: 876-885.
42. Wilking S, Van B, Belanger A, Kannel WB, Dágostino RB, Sfiel K. Determinants of isolated systolic hypertension. JAMA 1988; 260: 3451-3455.
43. Kannel WB. Hypertension: Relationship with other risk factors. Drugs. [Suppl.] 1986; 1:1-11.
44. Kannel WB, Dawber JR, Mc Gee DL. Perspectives in systolic hypertension: The Framingham study. Circulation 1980; 61: 1179-1182.
45. Cupples LA, DÁgostino RB, Kiely T. Some risk factors related to the annual incidence of cardiovasculardesease and death. Framinghan study, 30-year
follow-up.NIH Publication Nº 87-2703, pp. 1-462. Washington DC: U.S. Department of Commerce. National Technical information Service 1987.
46. Kannel WB, McGee DL, Castelli WP. Latest perspective on cigarette smoking and cardiovascular disease: The Framinghan study. J Cardiac Rehab
1984; 4: 267-277.
47. Weinstein MC, Coxson PG, Williams LW, et al. Forecasting coronary heart disease incidence, mortality, and cost: The Coronary Heart Disease Policy
Model. Am J Public Health 1987; 77: 1417-1426.
48. Murray CJK, Lopez AD. Global burden of disease summary, Havard School of Public Health Organization 1996.
49. Cardiovascular and Cerebrovascular Disease in the Américas. 1996, and IHF publication Pan American Health Organization data. FIAH Boletim, Dallas-USA.
1996; 18.
50. Greenland P. Compendio de cardiologia preventiva 1. American Heart Association. EPUC – Editora de publicações científicas Ltda 1994.
51. Lotufo PA. Epidemiologia da hipertensão arterial no Brasil. In: SOCESP II– Cardiologia: Atualização e reciclagem. São Paulo. Atheneu 1996; pp 327-331.
52. Saúde Brasil 2004 – Uma análise da situação de saúde. Ministério da Saúde – Brasilia/DF – Maio 2004.
53. Ramos LR, Santos FR, Marcopito LF. Morbidade e Mortalidade por doenças cardíacas em São Paulo. In: SOCESP II – Cardiologia: Atualização e reciclagem. São Paulo: Atheneu 1996; 1-4.
54. Doenças Cardiovasculares no Brasil – SUS – Coordenação de doenças cardiovasculares. Ministério da Saúde. Brasília-DF; 1993.
55. Fuchs FD, Hipertensão arterial sistêmica. Epidemiologia e prevenção. Arq Bras Cardiol 1994; 63: 443-444.
56. Edward FH, Clark RE, Schwartz M. Coronary artery bypass grafting: The Society of Thoracic Surgeons National Database experience. Ann Thorac Surg 1994;
57: 12-19.
57. Falke E, et al. Pathology of atherosclerotic plaque: stable, unstable, and infarctional. In: Roubin G, Califf R, O’Neil W (eds). Interventional Cardiovascular Medicine. New York: Churchill Livingstone; 1994. p. 57-68.
58. Glower DD, Spratt JA, Kabas JS, et al. Quantification of regional myocardial dysfunction after acute ischemic injury. Am J Physiol 1988; 255: H85-H93.
59. Hamm WC, Braunwald E. A classification of unstable angina revisited. Circulation 2000; 102: 118-42.
60. Braunwald E. Heart Disease – A Textbook of Cardiovascular Medicine. 6a ed, Philadelphia W.B Saunders 1992; p. 1874.
61. Braunwald E. Unstable angina: a classification. Circulation 1989; 80: 410-414.
62. Lima RC, Nery ACS, Pinheiro BB, et al. Diretrizes da cirurgia de revascularização miocárdica. Arq Bras Cardiol 2004; 82: 1-20.
63. Antman EM. The TIMI risk unstable angina/non-ST elevation MI: amethod for prognostication and therapeutic decision making. JAMA 2000; 248: 835-842.
64. Longmire W Jr, Cannon J, Kattus A. Direct vision coronary endarterectomy for angina pectoris. The New England journal of medicine 1958; 259: 993-1958.
65. Sabiston DC Jr: David Coston Sabiston, Jr., MD. A conversation with the Editor
[interview by William Clifford Roberts]. Am J Cardiol 1998; 82: 358-372.
66. Kolessov VI. Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris. J Thorac Cardiovasc Surg 1996; 54(4): 535-44.
67. Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg 1968; 5 334- 339.
68. Johnson WD, Flemma RJ, Lepley D Jr, Ellison EH. Extended treatment of severe coronary artery disease: A total surgical approach. Ann Surg 1969; 170: 460-470.
69. Garrett HE, Dennis EW, DeBakey ME. Aortocoronary bypass with saphenous vein graft. Seven-year follow-up. JAMA 1973; 223: 792-794.
70. Silva MAM; Oliveira RA; Martins AS; Andrade RR. Tratamento cirúrgico das cardiopatias adquiridas. In: Cataneo AJM, Kobayashi S. Clínica Cirúrgica- Faculdade de Medicina de Botucatu-UNESP. Rio de Janeiro: Revinter; 2003; 510-520.
71. Ministério da Saúde, Datasus 2005. URL: http://www.datasus.gov.br
72. Carvalho ACC, Oliveira EM, Souza JAM. Pós-operatório em cirurgia cardíaca. In: Knobel E. Condutas no paciente grave. São Paulo: Atheneu; 1999, p 1032- 1042.
73. Gibbon J Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minnesota medicine 1954; 37:171.
74. Utley JR. Cardiopulmonary bypass.Ann Thorac Surg. 1996 Mar;61(3):1042-3.
75. Hall TS. The pathophysiology of cardiopulmonary bypass. The risk and benefits of hemodilition. Chest 1995; 107: 1125-33.
76. Buffolo E, Gerola LR. Coronary artery bypass grafting without cardiopulmonary bypass through sternotomy and minimally invasive procedure. Int J Cardiol 1997; 62(1): 89-93.
77. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993; 55: 552-559.
78. Huang ZY, Yao B, Jiang HY, Xu MX. Changes in contents of inflammatory cytokine and troponin I in peri-operative periods of coronary artery bypass grafting with or without cardiopulmonary bypass. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2005; 17(3): 163-70.
79. Brasil LA, Gomes WJ, Salomão R, Buffolo E. Inflammatory response after revascularizartion with or without cardiopulmonary bypass. Ann Thorac Surg 1998; 6(1): 56-9.
80. Galantier J. Particularidades da circulação extracorpórea. In Auler Jr, Oliveira SA & colaboradores. Pós-operatório de Cirurgia Torácica e cardiovascular. Porto Alegre; 2004. p.153-157.
81. Elias DO, Souza MHL. Resposta do organismo humano à circulação extracorpórea. In: Fundamentos da circulação extracorpórea. Rio de Janeiro:
82. Hughes GC, Landalfo KP, Lowe JE, et al. Perioperative morbidity and mortality after transmyocardial laser revascularization: Incidence and risk factors for adverse events. J Am Coll Cardiol 1999; 33: 1021-1026.
83. Horvath KA, Cohn LH, Cooley DA, et al. Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial lases revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 1997, 113: 645-654.
84. Ribakove GH, Galloway AC, Grossi EA, et al. Port-access coronary artery bypass grafting. Semin Thorac Cardiovasc Surg. 1997, 9: 312-319.
85, Peters W. Minimally invasive cardiac surgery by cardioscapy. Aust J Cardovasc Thorac Surg. 1993, 2: 152.
86. Subramanian VA, McCabe JC, Geller CM. Minimally invasive direct coronary artery bypass grafting: Two-year clinical experience. The Annals of thoracic surgery 1997, 64: 1648-1655.
87. Loop FD. Coronary artery surgery: the end of beginning. 1998; 14: 554-71.
88. Favaloro RG. Tratamiento Quirurgico de la Arteriosclerosis Coronária. 1a ed.
Buenos Aires. Inter-Medica. 1973, 126p.
89. Chang BB, Darling RC3nd, Shah DM, Paty PS, Leather RP. Carotid
endarterectomy can be safely performed with acceptable mortality and
morbidity in patients requiring coronary artery bypass graft. Am J Surg 1994;
168: 94-97.
90. Westaby S, Parry A, Grebenik CR, Pillai R, Lamont P. Combined cardiac and abdominal aortic aneurysm operations. The dual operations on
91. Benetti FJ, Naselli G, Wood M, Geffner L. Direct Myocardial revascularization without extracorporeal circulation. Experience in 700 patients. Chest 1991;
100: 312-216.
92. Benetti FJ. Direct coronary surgery with saphenous vein bypass without either cardiopulmonary bypass or cardiac arrest. J Cardiovasc Surg 1985; 26: 17- 222.
93. Buffolo E, Andrade JC, Succi J, et al. Direct myocardial revascularization without cardiopulmonary bypass. Thorac Cardiovasc Surg 1985; 33: 26-29.
97. Baumgartner WA, Owens SG, Cameron DE, Reitz BA. The Johns Hopkins Manual of Cardiac Surgical Care. 1ª ed, StLouis Missouri, Mosby, 1994; p. 546.
98. Goyal V, Pinto RJ, Bhattacharya S. Alteration in pulmonary mechanics after coronary artery bypass surgery: comparison using internal mammary artery and saphenous vein grafts. Indian Heart J 1994; 46: 345-348.
94. Peters WS, Burdon TA, Stevens JH, et al. Port-access bilateral internal mammary artery grafting for left main disease: canine feasibility study. J Card Surg 1997; 12: 1-7.
95. Whittaker P, Raskusan K, Klner RA. Transmural channels can protect ischemic tissue. Assessment of long term myocardial response to laser and needle-made channels. Circulations 1996; 93: 143-152.
96. Cooley DA, Fraizier OH, Kadipasaoglu KA, Kadipasaoglu KA, Pehlivanoglu S, Shannon RL, Angeline P. Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. Tex Heart Inst J 1994; 21: 220-224.
99. Vargas FS, Cuckier A, Terra-Filho M, Hueb W, Teixeira LR, Light RW. Influence of atelectasis on pulmonary function after coronary artery bypass
grafting. Chest 1993; 104:343-437.
104. Gale GD, Sanders DE. Incentive spirometry : its value after cardiac surgery. Can Anaesth Soc J 1980; 27(5): 475-480.
100. Van Belle AF, Wesseling GP, Penn OC, Wouters EF, Postoperative pulmonary function abnormalities after coronary artery bypass surgery. Am J Respir Crit Care Med 1992; 86: 195-199.
101. Oikkonen M, Karjalainen K, Kahara V, Kuosa R, Schavikin L. Comparison of incentive spirometry and intermittent positive pressure breathing after coronary artery bypass graft. Chest 1991; 99(1): 60-65.
102. Arnio P, Kettunen S, Harjula A. Pleural and pulmonary complications after bilateral internal mammary artery grafting. Scand J Thorac Cardiovasc Surg
1991;17: 461-464.
103. Stock MC, Dows JB, Gauer PK, AlsterJM, Imrey PB. Prevention of postoperative pulmonary complications with CPAP, incentive spirometry and
conservative therapy. Chest 1985; 85: 151-157.
105. Ferdinande PG, Beets G, Michels A, Lesaffre E, Lauwers P. Pulmonary function tests after different techniques for coronary artery bypass surgery. Intensive Care Med 1988; 14: 623-627.
106. Matte P, Jacquet L, Van Dyck M, Goenen M. Effects of conventional physiotherapy, continuous positive airway pressure and non-invasive ventilatory support with bilevel positive airway pressure after coronary artery bypass grafting. Acta Anaesthesiol Scand2000; 44(1): 75-81.
107. Pereira EDB, Faresin SM, Fernandes ALG. Fatores de risco para complicações pulmonares no pós-operatório de cirurgia abdominal alta. J Pneumologia 1996; 22(1):19-26.
110. Davies JM.Preoperative respiratory evaluations and manangement for patients
with upper abdominal surgery. 1991; 64:329-349.
111. Taylor G, Mikel FL, Moses HW, Dove JT, Katholi RE, Malik SA, et al. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol. 1990;
65: 309-313.
108. Lawrence VA, Hilsenbeck SG, Mulrow CD, Dhanda R, Sapp J, Page CP. Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med1995; 10: 671-8.
109. Ephgrave KS, Kleiman-Wexler R, Pfaller M, et al. Postoperative pneumonia: a prospective study of risk factors and morbidity. Surgery 1993; 114:815-821.
Yale J Biol Med
112. Gardner B, Palasti SA. Comparison of hospital costs and mortality between octogenarians and other patients undergoing general surgical operations. Surg Gynecol Obstet 1990; 171: 299-304.
113. Hart Sk, Dubbs W, Gil A, Myers-Judy M. The effects of therapist-evaluation of orders and interaction with physicians on appropriateness of Respiratory Care. Respir Care 1989; 34:185-190.
114. Carrel TP, Eisinger E, Vogt M, Turina MI. Pneumonia after cardiac surgery is predictable by tracheal aspirates but cannot be prevented by prolonged antibiotic prophylaxis. Ann Thorac Surg 2001; 72: 143-8.
115. Jain U, Rao TL, Kumar P, Kleinman BS, Belusko RJ, Kanuri DP, et al. Radiographic pulmonary abnormalities after different types of cardiac surgery. J Cardiothorac Vasc Anesth 1991; 5: 592-5.
116. Molbouisson LMS, Carmona MJC, Auler Jr JOC. Assistência ventilatória no período pós-operatório imediato da cirurgia cardíaca. In Auler Jr, Oliveira SA & colaboradores. Pós-operatório de Cirurgia Torácica e cardiovascular. Porto Alegre: Artmed; 2004. p. 183-194.
123. Malbouisson LM, Busch CJ, Puybasset L, Lu Q, Cluzel P, Rouby JJ. Role of heart in loss of operation characterizing lower lobes in acute respiratory distress
syndrome. CT Scan ARDS Study Group. 2000; 161:
2005-2012.
117. Leslie K, Sessler DI. The implications of hypothermia for early tracheal extubation following cardiac surgery. J Cardiothorac Vasc Anesth 1998; 12: 30- 41.
118. Sykes LA, Bowe EA. Cardiorespiratory effects of anesthesia. Clin Chest Med 1993; 14: 211-225.
119. Ford GT, Rosenal TW, Clergue F, Whitelaw WA. Respiratory physiology in upper abdominal surgery. Clin Chest Med 1993; 14:237-52.
120. Knill RL. Control of breathing: effects of analgesia, anaesthetic and neuromuscular blocking drugs. Can Anaesth Soc J 1988; S4-S8.
121. Tenling A, Hachenberg T, Tyden H, Wegenius G, Hendenstierna G. Atelectasis and gas exchange after cardiac surgery. Anesthesiology 1998; 89: 371-378.
122. Froese AB, Bryan AC. Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology 1974; 41(3): 242-255.
124. Magnusson L, Zemgulis V, Wicky S, Tyden H, Thelin S, Hedenstierna G. Atelectasis is a major caused of hypoxemia and shunt after cardiopulmonary bypass: an experimental study. Anesthesiology 1997; 87: 1153-63.
129. Mackenzie CF, Ciesla N, Imle PC, et al. Chest Physiotherapy in Intensive Care Unit. Baltimore: Williams and Wilkins, 1981.
125. Auler R joc, Zin WA, Caldeira MP, Cardoso WV, Saldiva PH. Pré-and postoperative inspiratory mechanics in ischemic and valvular heart disease.
Chest, 1987, 92: 984-90.
126. American Physical Therapy Association. Guide to physical therapist practice.
2nd. ed. Phys Ther 2001; 81:9-746.
127. Rebelatto JR, Botomé SP. Fisioterapia no Brasil: fundamentos para uma ação preventiva e perspectivas profissionais. São Paulo: Manole;1999.
128. Muller AP, Paula IMT. Fisioterapia aplicada aos pacientes submetidos a
revascularização do miocárdio (ponte safena). Fisioterapia em movimento
1990; 3(1): 25-31.
130. Kigin CM. Chest physical tjerapy for the postoperative or traumatic injury patient. Phys Ther 1981; 61: 1724-1736.
131. Hardy KA, Anderson BD: Noninvasive clearence of airway secretions. Respir Care clinics of North America 1996; 2: 323-345.
132. Frownfelter DL, Dean E. Principles and practice of cardiopulmonary physical therapy. St Louis: Mosby; 1996ed.
133. Hardy KA. A review of airway clareance: New techniques, indications, and recommendations. Respir Care 1994; 39: 440-452.
134. Dean E, Ross J. Discordance between cardiopulmonary physiology and physical therapy. Toward a rational basis for practice. Chest 1992; 101: 1694- 1698.
135. Eid N et al. Chest physiotherapy in review. Respir Care 1991;36: 270-282.
142. Dohi S, Gold MI. Comparison of two methods of postoperative Respiratory Care. Chest 1978; 73:592-595.
136. Zikria BA, Spencer JL, Michailoff T, et al. Breathing patterns in preoperative, postoperative and critically ill patients. Surg Forum1971; 22: 40-41.
137. Williams JV, Tierney DF, Parker HR. Surface forces in the lung atelectasis, and transpulmonary pressure. J Appl Physiol. 1960; 21: 819- 827.
138. Menkes HA, Traystman RJ. Collateral ventilations. Am Rev Respir Dis1977; 116:287-309.
139. Wilkins RL; Scalan CL. Terapia de expansão pulmonar. In: Scalan CL; Wilkins RL; Stoller. Fundamentos da terapia respiratória de Egan (Título do original: Egan’s fundamentals of Respir Care – Seventh Editions). Rio de Janeiro: Manole; 2000. p. 797-816.
140. Grant-Paterson L & Moodie N B. Incentive spirometry: an adjunct to chest
physiotherapy. Physiother Can1985; 37(6): 388-393.
141. American Associations for Respir Care (AARC): Clinical practice guideline:
incentive spirometry. Respir Care 1991; 36(12): 1402-1405.
143. Colgan FJ, Mahoney PD, Fanning GL. Resistance breathing (blow bottles) and sustained hyperinflations in the treatment of atelectasis. Anesthesiology 1970; 32:543-550.
144. Scuderi J, Olsen GN. Respiratory Therapy in the management of postoperative complications. Respir Care 1989; 34:281-191.
148. Crowe JM, Bradley CA. The effectiveness of incentive spirometry with physical therapy for high-risk patients after coronary artery bypass surgery. Phys Ther 1997; 77(3): 260-268.
145. Rau JL, Thomas L, Haynes RL. The effect of method of administering
incentive spirometry on postoperative pulmonary complications in coronary
artery bypass patients. Respir Care 1988; 33: 771-778.
146. Bartlett RH. Respiratory therapy to prevent pulmonary complications of surgery. Respir Care 1984; 29: 667-679.
147. Van de Water JM, Watring WC, Linton LA, et al. Prevention of postoperative pulmonary complications. Surg Gynecol Obstet 1972; 135:1-5.
149. Kips JC. Preoperative pulmonary evaluation. Acta Clin Belg. 1997; 52: 301- 305.
150. Weiner P, Man A, Weiner M, et al. The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection. Thorac Cardiovasc Surg 1997; 113: 552-557.
151. Hall JC, Tarala RA, Tapper J, et al. Prevention of pulmonary complications after abdominal surgery: a randomized clinical trial. Br Med J. (BMJ) 1996;